Medical cannabinoids for cancer cachexia: A systematic review and meta-analysis

6/23/19–Cancer cachexia (CCA), an intractable and ineffective metabolic syndrome that attacks 50–80% of cancer patients, reduces patient’s life quality, affects the efficacy of treatment, and then increases their mortality. However, there are no established therapeutic strategies for CCA in the world. In this study, the positive and negative effects of cannabinoid in the treatment of CCA are assessed. Results showed cannabinoid is effective in increasing appetite in cancer patients; however, it declines the quality of life, which may be due to the side effects of cannabinoid. Read